Charles L. Cooney is Robert T. Haslam Professor Emeritus in the MIT Department of Chemical Engineering. He serves as a consultant to and/or director of a number of biotech and pharmaceutical companies and is on several boards of professional journals.

Derrick Katayama, Ph.D. is the Principal Scientist at Legacy BioDesign, LLC. He has experience working on peptide and protein formulation at Amylin Pharmaceuticals Inc., with formulation and characterization of protein subunit vaccine candidates at MedImmune Inc., and at Boehringer Ingelheim in Fremont, CA, participating in the Analytical and Formulation Development group responsible for formulation development of monoclonal antibodies.

Dr. Mark Manning is Chief Scientific Officer, Legacy BioDesign, LLC. Dr. Manning has been involved in the development of biopharmaceutical products since 1988.

Bernhardt L. Trout is the Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering at MIT. He received his S.B. and S.M. degrees from MIT and his Ph.D. from the University of California at Berkeley. In addition, he performed post-doctoral research at the Max-Planck Institute.